Skip to main content

Table 3 List of the primary antibodies used in this study

From: Microglial exosomes alleviate intermittent hypoxia-induced cognitive deficits by suppressing NLRP3 inflammasome

Antibody

Catalogue number

Brand

Dilution

MW (kDa)

Application

Iba1

A20844

Abclonal

1:100

NA

IF

MAP2

sc-74,421

Santa Cruz

1:100

NA

IF

NeuN

Ab177487

abcam

1:500

NA

IF

iNOS

13,120

CST

1:200

NA

IF

NLRP3

MAB7578

R&D system

12.5ug/ml

NA

IF

NLRP3

ab263899

abcam

1:1000

118

WB

Cleaved Caspase1

67,314

CST

1:1000

20/22

WB

GSDMD

Ab209845

abcam

1:1000

32/53

WB

ASC

67,824

CST

1:1000

22

WB

CD63

ab134045

abcam

1:1000

30–65

WB

Alix

2171

CST

1:1000

95

WB

TSG101

72,312

CST

1:1000

50

WB

HIF1α

14,179

CST

1:1000

120

WB

p-tau

9632

CST

1:1000

50–80

WB

p-tau

49,561

CST

1:200

NA

IF

β-actin

4970

CST

1:1000

45

WB

  1. Abcam: Abcam, Cambridge, MA, USA; CST: Cell Signaling Technology, Danvers, MA, USA; MW: molecular weight; NA: not applicable; Santa Cruz: Santa Cruz Biotechnology, Santa Cruz, CA, USA; R&D system: R&D system,USA; Abclonal:Abclonal, China; WB: western blot; IF: immunofluorescence.